CRI-ENCI Ninth International Cancer
Immunotherapy Conference

Program

Sept. 10-12, 2025 | Utrecht, The Netherlands

Pre-Conference Program: Sept. 9, 2025

Scientific Program

The Ninth International Cancer Immunotherapy Conference (CICON25) successfully took place in Utrecht from September 9–12, 2025.

With the theme Translating Science into Survival, CICON25 brought together leading experts to spotlight new research and critical discussions that push the frontiers of cancer treatments.

The program featured plenary lectures, proffered talks, roundtable discussions, poster sessions, and industry exhibits. Selected abstracts highlighted the latest advancements in cancer immunotherapy, while poster sessions provided a platform for in-depth scientific exchange and collaboration.

Ahead of the main conference, the pre-conference day on September 9 included a dedicated workshop on tertiary lymphoid structures and a symposium on neuro-immuno-oncology hosted by L’Institut Servier, exploring interactions between the nervous system, the immune system, and cancer.

You can still view the full CICON25 program below.

Preliminary Program

[pac_dtm_gallery_item id="958"]
[pac_dtm_gallery_item id="961"]
[pac_dtm_gallery_item id="969"]
[pac_dtm_gallery_item id="985"]

CONFERENCE CO-CHAIRS

Özlem Türeci, Mainz, Germany
Cornelis M. Melief, Leiden, The Netherlands
Nina Bhardwaj, New York, USA
Cassian Yee, Houston, USA

CICON25 SCIENTIFIC PROGRAM COMMITTEE

Sergio Abrignani, National Institute of Molecular Genetics (INGM), Italy
Valsamo Anagnostou, Johns Hopkins Medicine, USA
Ana Arance, Hospital Clinic Barcelona, Spain
Marcel van den Brink, City of Hope, USA
Vincenzo Bronte, Istituto Oncologico Veneto IRCCS, Italy
Lorenzo Galluzzi, Fox Chase Cancer Center, USA
Manel Juan, Hospital Clinic Barcelona, Spain
Christina Leslie, Memorial Sloan Kettering Cancer Center, USA
Yifat Merbl, Weizmann Insitute of Science, Israel
Catherine Sautes-Fridman, Cordeliers Research Center, France
Matthew Spitzer, UC San Francisco, USA